Elizabeth(Gruber)BremMD(She/Her)
[Pronunciation: Braim]
Hematology • Orange, CAHematologic Oncology
Associate Professor of Medicine, UC Irvine
Dr. Brem is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 The City Drive South
Orange, CA 92868Phone+1 714-456-8000Fax+1 714-456-3810- Is this information wrong?
Summary
- Dr. Elizabeth Brem is an oncologist in Orange, CA and is affiliated with UC Irvine Medical Center. She received her medical degree from University at Buffalo, School of Medicine and Biomedical Sciences and has been in practice 7 years. She specializes in lymphoma and hematologic malignancies.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2010 - 2013
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2010
Canisius CollegeB.S., Major in Biochemistry, minor in Theatre Arts & Chemistry, Summa Cum Laude, 2002 - 2006
Certifications & Licensure
CA State Medical License 2016 - 2024
MA State Medical License 2012 - 2017- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Coltman Fellowship SWOG, 2021
- Lymphoma Clinic Research Mentoring Program Lymphoma Research Foundation, 2018
- Young Investigator Training Course SWOG Cancer Research Network, 2018
- Join now to see all
Clinical Trials
- Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia Start of enrollment: 2020 Dec 02
- Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma Start of enrollment: 2021 May 20
Publications & Presentations
PubMed
- 1 citationsLooking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities.Elizabeth A Brem, Laurie H Sehn> ;Seminars in Hematology. 2023 Nov 1
- 3 citationsTargeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.Bradley Haverkos, Onder Alpdogan, Robert Baiocchi, Jonathan E Brammer, Tatyana A Feldman, Marcelo Capra, Elizabeth A Brem, Santosh Nair, Phillip Scheinberg, Juliana Pe...> ;Blood Advances. 2023 Oct 24
- 1 citationsAnakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.Benjamin J Lee, Yen Cao, Pongthep Vittayawacharin, Ghaydá É'Leima, Sherif Rezk, Jack Reid, Elizabeth A Brem, Stefan O Ciurea, Piyanuch Kongtim> ;European Journal of Haematology. 2023 Sep 1
- Join now to see all
Journal Articles
- The Acute Hemolytic Anemias: The Importance of Emergency Diagnosis and ManagementRobertson JJ, Brem E, and Koyfman A, J Emerg Med, 1/10/2017
- BOK: Oddball of the BCL-2 FamilyBrem EA and Letai AG, Trends in Cell Biology, 1/1/2016
- Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma?Brem E and Davids M, Leukemia and Lymphoma, 1/1/2014
- Join now to see all
Abstracts/Posters
- Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refracto...Elizabeth Brem, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Functional Characterization of BCL2-Family Members Identifies BH3 Mimetics As Potential Therapeutics in T-Cell LymphomasKoch R, Brem E, Clark R, Kupper T, Letai A, Weinstock DM, Blood, 1/1/2016
- BH3 Mimetics May Have Utility in Cutaneous T Cell LymphomasBrem E, Koch R, Clark R, Kupper T, Weinstock D, Letai A, ASH Meeting on Lymphoma Biology, 1/1/2016
- Join now to see all
Lectures
- Statins Enhance the Efficacy of BH3 Mimetics in Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Highlights of ASH 2017: LymphomasHuntington Beach, CA - 1/28/2018
- 81yoM with Aggressive LymphomaLos Angeles, CA - 1/6/2018
- Join now to see all
Authored Content
- Learning to LeadNovember 2020
- Grief TacosNovember 2019
- Modern Medicine and Modern StoicismJuly 2019
Press Mentions
Unraveling When and How to Perform MRD Testing in Mantle Cell LymphomaNovember 23rd, 2022- Elizabeth Brem, MD, on Frontline Management of CLLJune 24th, 2022
- EM@3AM: PolycythemiaDecember 5th, 2020
- Join now to see all
Committees
- Member, ASH Publications Committee 2022 - Present
- Active member, SWOG Lymphoma Working Group 2016 - Present
- Lymphoma/CLL committee chair, UC Hematologic Malignancies Consortium 2016 - Present
- Member, ASH Communications Committee 2015 - 2017
- Member, ASH Trainee Council 2014 - 2016
Professional Memberships
- Member
- Associate Member
- Member
- Member
Industry Relationships
- Consulting, Janssen2017 - Present
- Consulting, PharmacyclicsAd Board participation2017 - Present
External Links
- LinkedInhttps://www.linkedin.com/in/lizbrem
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
